Dietary prevention of malignant glioma aggressiveness, implications in oxidant stress and apoptosis

International Journal of Cancer

Volumn 123, Issue 2, 2008, Pages 288-295

  Pouliquen, Daniel ^a,b,d   Olivier, Christophe ^a,b   Hervouet, Eric ^a,b   Pedelaborde, Francois ^a,b   Debien, Emilie ^a,b   Le Cabellec, Marie Thérèse ^a,b   Gratas, Catherine ^a,b   Homma, Taku ^c   Meflah, Khaled ^a,b   Vallette, Francois M ^a,b   Menanteau, Jean ^a,b  

^a INSTITUT DE BIOLOGIE   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d INSERM   (France)

Author keywords

Apoptosis; Diet; Glioma; Oxidant stress; Phytochemicals

Indexed keywords

CATALASE; KI 67 ANTIGEN; PLANT MEDICINAL PRODUCT; PROTEIN BCL 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOD 1; TRANSCRIPTION FACTOR SOD 2; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ETHYLNITROSOUREA; RNA; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TUMOR; CANCER GROWTH; CANCER PREVENTION; CANCER SURVIVAL; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; INCIDENCE; LIVER MITOCHONDRION; LIVER WEIGHT; MALE; NONHUMAN; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; PROGENY; RAT; SEX DIFFERENCE; SURVIVAL TIME; UPREGULATION; WEIGHT REDUCTION; ANIMAL; CHEMICALLY INDUCED DISORDER; DIET THERAPY; FRUIT; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; VEGETABLE;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; BRAIN NEOPLASMS; CELL PROLIFERATION; ETHYLNITROSOUREA; FEMALE; FRUIT; GLIOMA; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRIA, LIVER; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PREGNANCY; RATS; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; VEGETABLES;

EID: 44949198258     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23513     Document Type: Article

References (48)

1. Pouliquen D, Olivier C, Debien E, Meflah K, Vallette FM, Menanteau J. Changes in liver mitochondrial plasticity induced by brain tumor. BMC Cancer 2006;6:234.
2. Fecci PE, Mitchell DA, Whitesides JF, Xie W, Friedman AH, Archer GE, Herndon JE, Jr, Bigner DD, Dranoff G, Sampson JH. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant gliomas. Cancer Res 2006;66:3294-302.
3. Dix AR, Brooks WH, Roszman TL, Morford LA. Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 1999;100:216-32.
4. Stover JF, Hopf NJ, Pemeczky A, Kempski OS. Unspecific metabolic blood parameters as used in clinical routine may differentiate malignant from benign cerebral tumors. Cancer Lett 1995;95:147-52.
5. Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 2005;54:540-5.
6. Gasparini G, Morabito A, Magnani E, Gattuso D, Capaccetti B, Alberti AM. Thalidomide: an old sedative-hypnotic with anticancer activity? Curr Opin Investig Drugs 2001;2:1302-8.
7. Chen H, Ward MH, Tucker KL, Graubard BI, McComb RD, Potischman NA, Weisenburger DD, Heineman EF. Diet and risk of adult glioma in eastern Nebraska. United States Cancer Causes Control 2002;13:647-55.
8. Tedeschi-Blok N, Lee M, Sison JD, Miike R, Wrensch M. Inverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control study. BMC Cancer 2006;6:148.
9. Aggarwal BB, Shishodia S. Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006;72:1605-21.
10. Issa AY, Volate SR, Wargovich MJ. The role of phytochemicals in inhibition of cancer and inflammation: new directions and perspectives. J Food Comp Anal 2006;19:405-19.
11. Koestner A, Swenberg JA, Wechsler W. Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats. Am J Pathol 1971;63:37-56.
12. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 2004;134:3479S-34785S.
13. Shishodia S, Chaturvedi MM, Aggarwal BB. Role of curcumin in cancer therapy. Curr Prob Cancer 2007;31:243-305.
14. Thomson M, Ali M. Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent. Curr Cancer Drug Targets 2003;3:67-81.
15. Verhoeven DT, Verhagen H, Goldbohm RA, Van den Brandt PA, van Poppel G. A review of mechanisms underlying anticarcinogenicity by Brassica vegetables. Chem Biol Interact 1997;103:79-129.
16. Yue PY, Mak NK, Cheng YK, Leung KW, Ng TB, Fan DT, Yeung HW, Wong RN. Pharmacogenomics and the Yin/yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med 2007;2:6.
17. Doss MX, Porta SP, Hescheler J, Sachinidis A. Trapping of growth factors by catechins: a possible therapeutic target for prevention of proliferative diseases. J Nutr Biochem 2005;16:259-66.
18. Laurent A. Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A, Levy E, Goldwasser F, Panis Y, Soubrane O, Weill B, Batteux F. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 2005;65:948-56.
19. Kinnula VL, Crapo JD. Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 2004;36:718-44.
20. Li D, Ueta E. Kimura T, Yamamoto T, Osaki T. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci 2004;95:644-50.
21. Pouliquen D, Foussard F, Tanguy G, Roux J, Malthièry Y. Total and structured water in cancer: an NMR experimental study of serum and tissues in DMBA-induced OF1 mice. Cell Mol Biol 2001;47:947-57.
22. Fleige S, Walf V, Huch S, Prgomet C, Sehm J, Pfaffl MW. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 2006;28:1601-13.
23. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper - Excel-based tool using pair-wise correlations. Biotechnol Lett 2004;26:509-15.
24. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
25. Rickwood D, Wilson MT, Darley-Usmar VM. Isolation and characteristics of intact mitochondria. In: Darley-Usmar VM, Rickwood D, Wilson MT, eds. Mitochondria, a practical approach. Oxford: IRL Press, 1987. 1-16.
26. Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD. Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 2005;114:797-805.
27. Lee M, Wrensch M, Miike R. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control 1997;8:13-24.
28. Hu J, Johnson KC, Mao Y, Guo L, Zhao X, Jia X, Bi D, Huang G, Liu R. Risk factors for glioma in adults: a case-control study in northeast China. Cancer Detect Prev 1998;22:100-8.
29. Gursoy E, Cardounel A, Hu Y, Kalimi M. Biological effects of long-term caloric restriction: adaptation with simultaneous administration of caloric stress plus repeated immobilization stress in rats. Exp Biol Med 2001;226:97-102.
30. Yilmaz N, Dulger H, Kiymaz N, Yilmaz C, Bayram I, Ragip B, Oger M. Lipid peroxidation in patients with brain tumor. Int J Neurosci 2006;116:937-43.
31. Wozniak B, Wozniak A, Kasprzak HA, Drewa G, Mila-Kierzenkowska C, Drewa T, Planutis G. Lipid peroxidation and activity of some antioxidant enzymes in patients with glioblastoma and astrocytoma. J Neurooncol 2007;81:21-6.
32. Ceccarelli D, Gallesi D, Giovannini F, Ferrali M, Masini A. Relationship between free iron level and rat liver mitochondrial dysfunction in experimental dietary iron overload. Biochem Biophys Res Commun 1995;209:53-9.
33. Dutra F, Bechara EJH. Aminoacetone induces iron-mediated oxidative damage to isolated rat liver mitochondria. Arch Biochem Biophys 2004;430:284-9.
34. Musci G, Persichini T, Casadei M, Mazzone V, Venturini G, Ploticelli F, Colasanti M. Nitrosative/oxidative modifications and ageing. Mech Ageing Dev 2006;127:544-51.
35. Pennington JAT, ed. Bowes and Church's food values of portions commonly used, 16th ed. Philadelphia: J. B. Lippincott, 1994.
36. Stehbens WE. Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc. Exp Mol Pathol 2003;75:265-76.
37. Yamagushi M, Kura M, Okada S. Role of zinc as an activator of mitochondrial function in rat liver. Biochem Pharmacol 1982;31:1289-93.
38. Kahl R, Kampkötter A, Wätjen W, Chovolou Y. Antioxidant enzymes and apoptosis. Drug Metab Rev 2004;36:747-62.
39. Sallinen PK, Sallinen SL, Helen PT, Rantala IS, Rautiainen E, Helin HJ, Kalimo H, Haapasalo HK. Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes. Neuropathol Appl Neurobiol 2000;26:319-31.
40. Newcomb EW, Bhalla SK, Parrish CL, Haves RL, Cohen H, Miller DC. Bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol 1997;94:369-75.
41. Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J, Reed JC. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin. Am J Pathol 1997;150:805-14.
42. Li D, Ueta E, Kimura T, Yamamoto T, Osaki T. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci 2004;95:644-50.
43. Green DR, Evan GI. A matter of life and death. Cancer Cell 2002;1:19-30.
44. Landriscina M, Remiddi F, Ria F, Palazzotti B, De Leo ME, Iacoangeli M, Rosselli R, Scerrati M, Galeotti T. The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin. Br J Cancer 1996;74:1877-85.
45. Ria F, Landriscina M, Remiddi F, Rosselli R, Iacoangeli M, Scerrati M, Pani G, Borrello S, Galeotti T. The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications. Br J Cancer 2001;84:529-34.
46. Wong GH, Goeddel DV. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 1988;242:941-4.
47. Smith PS, Zhao W, Spitz DR, Robbins ME. Inhibiting catalase activity sensitizes 36B10 glioma cells to oxidative stress. Free Radic Biol Med 2007;42:787-97.
48. Loo G. Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation. J Nutr Biochem 2003;14:64-73.